Clinical Trial Update: REPRISE Next Generation Delivery System [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating Boston Scientific's REPRISE Next Generation Delivery System for aortic stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Stenosis | NA | Status: COMPLETED